Funding
← Back to your selection

European Innovation Council (EIC) Fund

Activity from announced rounds

Activity in this selectionOct 24, 2026 · Healthtech · Jan 1, 2026
Rounds participated in
2
Confirmed lead rounds
0
1 roles undisclosed
New companies
2
First participation on record · 0 follow-on
Funding in participating rounds
$58.2M
2 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1

By primary sector

Biotech2

By country

Netherlands1
Spain1

Rounds

2 in this selection
Vaxdyn

Vaxdyn develops vaccines against antimicrobial-resistant bacteria, including its lead candidate K-VAX for Klebsiella pneumoniae and Acinetobacter baumannii.

€11MSeries A
Participant
Leyden Laboratories

Develops antibody-based nasal sprays intended to prevent influenza and other respiratory-virus infections.

€40MSeries B
Role not disclosed